Enhanced single-cell RNA-seq workflow reveals coronary artery disease cellular cross-talk and candidate drug targets
Wei Feng(University of Virginia Medical Center), Clint L. Miller(University of Virginia), Huize Pan(Columbia University Irving Medical Center), José Verdezoto Mosquera(University of Virginia), Chani J. Hodonsky(University of North Carolina at Chapel Hill), Nelson B. Barrientos(University of Virginia), Lotte Slenders(Utrecht University), Katherine Owsiany(Cornell University), Muredach P. Reilly(Columbia University Irving Medical Center), Doris Wong(National Institutes of Health), Gerard Pasterkamp(University Medical Center Utrecht), Gabriel F. Alencar(Carter Center), Sander W. van der Laan(Utrecht University), David Mai(University of Pennsylvania), Yipei Song(University of Virginia), Christina A. Gancayco(University of Virginia), Bohdan B. Khomtchouk(University of Indianapolis), Gary K. Owens(University of Virginia), Michal Mokrý(Utrecht University), Mingyao Li(California University of Pennsylvania), Adam W. Turner(University of Virginia), Alexandra V. Ligay(University of Chicago)
Cited by 56
Related Papers
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
|Nature Genetics|2006|2.3k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k
Vascular Smooth Muscle Cells in Atherosclerosis
|Circulation Research|2016|2.1k